You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

accelerated phase chronic myelogenous leukemia

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myelogenous Leukemia - Chronic Phase Trial (asciminib)

Recruiting
  • Chronic Myelogenous Leukemia - Chronic Phase
  • Birmingham, Alabama
  • +25 more
Jan 10, 2023

Leukemia Trial in Houston (Dasatinib, Decitabine)

Terminated
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 29, 2020

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 15, 2022

Philadelphia Chromosome Positive Chronic Myelogenous Leukemia Trial in Worldwide (Nilotinib + LDE225)

Completed
  • Philadelphia Chromosome Positive Chronic Myelogenous Leukemia
  • Nilotinib + LDE225
  • Toronto, Ontario, Canada
  • +6 more
Dec 6, 2020

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Jun 24, 2022

Leukemia, Myeloid, Chronic Trial in Germany, United States (LBH589)

Terminated
Has Results
  • Leukemia, Myeloid, Chronic
  • Duarte, California
  • +25 more
Jul 14, 2021

Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, Recurrent Acute Lymphoblastic

Active, not recruiting
  • Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 2, 2022

Chronic Myelogenous Leukemia - Chronic Phase Trial in Avignon (APN and medical management, Medical management, Quality of life

Not yet recruiting
  • Chronic Myelogenous Leukemia - Chronic Phase
  • APN and medical management
  • +3 more
  • Avignon, Provence-Alpes-Côte d'Azur, France
    Centre Hospitalier d'Avignon, Hôpital Henri Duffaut
Oct 13, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Obinutuzumab, Rituximab)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Dec 5, 2022

Chronic Myelogenous Leukemia Trial in Beijing (TGRX-678)

Recruiting
  • Chronic Myelogenous Leukemia
  • Beijing, Beijing, China
    Peking University People's Hospital
Jun 27, 2022

Chronic Phase Chronic Myeloid Leukemia, Accelerated Phase Chronic Myeloid Leukemia, Blastic Phase Chronic Myeloid Leukemia Trial

Completed
  • Chronic Phase Chronic Myeloid Leukemia
  • +4 more
  • Toronto, Ontario, Canada
    Princess Margaret Hospital / University Health Network
Oct 29, 2020

Real-World Usage of Asciminib Among Chronic Myeloid Leukemia in

Completed
  • Chronic Myeloid Leukemia
    • East Hanover, New Jersey
      Novartis
    Nov 20, 2023

    Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia Trial in Worldwide (nilotinib)

    Completed
    Has Results
    • Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia
    • Loma Linda, California
    • +35 more
    Mar 25, 2021

    Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission Trial (Asciminib, Imatinib)

    Not yet recruiting
    • Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission
    • (no location specified)
    Jun 7, 2022

    Ponatinib in CML Patients in Chronic Phase

    Recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • Therapeutic drug monitoring
    • Molecular Response
    • Cagliari, Italy
    • +4 more
    Nov 3, 2023

    Outcomes in Chronic Myeloid Leukaemia

    Completed
    • Chronic Myeloid Leukaemia
      • York, United Kingdom
        Haematological Malignancy Research Network
      Jun 7, 2023

      Chronic Myeloid Leukemia Any Phase Treated With Ponatinib at Any

      Active, not recruiting
      • Chronic Myeloid Leukemia, Chronic Phase
        • Jena, Germany
          University Hospital Jena
        Jan 17, 2023

        Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia

        Recruiting
        • Chronic Phase Chronic Myelogenous Leukemia
        • +3 more
        • Houston, Texas
          M D Anderson Cancer Center
        Aug 11, 2022

        Leukemia, Chronic Myelogenous Trial in Japan (Bosutinib)

        Completed
        Has Results
        • Leukemia, Chronic Myelogenous
        • Toyoake-City, Aichi, Japan
        • +20 more
        Apr 26, 2022

        CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

        Recruiting
        • CML
        • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
        • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
          FUNDALEU
        Jun 29, 2023

        Chronic Myeloid Leukemia, BCR/ABL-Positive Trial in Taipei

        Not yet recruiting
        • Chronic Myeloid Leukemia, BCR/ABL-Positive
          • Taipei, Taiwan
            National Taiwan University Hospital
          Jul 24, 2022

          Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in

          Recruiting
          • Acute Biphenotypic Leukemia
          • +13 more
          • Houston, Texas
            M D Anderson Cancer Center
          Jan 19, 2023

          Chronic Myelogenous Leukemia Patients Treated With Imatinib

          Recruiting
          • Chronic Myelogenous Leukemia
          • Chart Review
          • Houston, Texas
            University of Texas MD Anderson Cancer Center
          Feb 8, 2022

          Asciminib RMP Study

          Not yet recruiting
          • Chronic Myeloid Leukemia
          • Asciminib
          • (no location specified)
          Jul 5, 2023

          According to Molecular Identification at Diagnosis

          Not yet recruiting
          • Chronic Myeloid Leukemia
          • Next Generation Sequencing (DNA and RNA)
          • (no location specified)
          Oct 28, 2022